| http://www.w3.org/ns/prov#value | - increasing manufacturers' Medicaid rebate liability; ??expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program; ??expansion of healthcare fraud and abuse laws, including the False Claims Act and the Anti-Kickback Statute, new government
|
